欧盟EMA药品数据库-欧盟集中审批药品（European Medicines Agency Authorisation of Medicines DataBase）

商品名称	适用类别	通用名称	活性成分	产品号	上市许可开发者/申请人/持有人	上市许可日期	许可状态
Vyjuvek	Human	beremagene geperpavec	Beremagene geperpavec	EMEA/H/C/006330	Krystal Biotech Netherlands B.V.	2025/04/23	Authorised
Lynozyfic	Human	linvoseltamab	linvoseltamab	EMEA/H/C/006370	Regeneron Ireland Designated Activity Company (DAC)	2025/04/23	Authorised
Leqembi	Human	Lecanemab	Lecanemab	EMEA/H/C/005966	Eisai GmbH	2025/04/15	Authorised
Datroway	Human	datopotamab deruxtecan	datopotamab deruxtecan	EMEA/H/C/006547	Daiichi Sankyo Europe GmbH	2025/04/04	Authorised
Dyrupeg	Human	pegfilgrastim	pegfilgrastim	EMEA/H/C/006407	CuraTeQ Biologics s.r.o	2025/03/28	Authorised
Eltrombopag Accord	Human	eltrombopag	eltrombopag olamine	EMEA/H/C/006459	Accord Healthcare S.L.U.	2025/03/28	Authorised
Tivdak	Human	tisotumab vedotin	tisotumab vedotin	EMEA/H/C/005363	Pfizer Europe MA EEIG	2025/03/28	Authorised
Capvaxive	Human	pneumococcal polysaccharide conjugate vaccine (21-valent)	pneumococcal polysaccharide serotype 3, 6A, 7F, 8, 9N, 10A, 11A, 12F, 15A, 15B de-O-acetylated, 16F, 17F, 19A, 20A, 22F, 23A, 23B, 24F, 31, 33F and 35B conjugated to CRM197 carrier protein	EMEA/H/C/006267	Merck Sharp & Dohme B.V.	2025/03/24	Authorised
Rytelo	Human	imetelstat	imetelstat	EMEA/H/C/006105	Geron Netherlands B.V.	2025/03/07	Authorised
Wainzua	Human	eplontersen	eplontersen sodium	EMEA/H/C/006295	AstraZeneca AB	2025/03/06	Authorised
Tuzulby	Human	methylphenidate hydrochloride	methylphenidate hydrochloride	EMEA/H/C/005975	Neuraxpharm Pharmaceuticals S.L.	2025/02/28	Authorised
Vimkunya	Human	Chikungunya vaccine (recombinant, adsorbed)	Chikungunya virus (CHIKV) virus-like particle (VLP) proteins (capsid protein (C) and envelope proteins E1 and E2) derived from CHIKV Senegal strain 37997 produced in human embryonic kidney cells by recombinant DNA technology, adsorbed on aluminium hydroxide, hydrated	EMEA/H/C/005470	Bavarian Nordic A/S	2025/02/28	Authorised
Paxneury	Human	guanfacine	guanfacine hydrochloride	EMEA/H/C/006312	Neuraxpharm Pharmaceuticals S.L.	2025/02/26	Authorised
Stoboclo	Human	denosumab	denosumab	EMEA/H/C/006156	Celltrion Healthcare Hungary Kft.	2025/02/14	Authorised
Osenvelt	Human	denosumab	denosumab	EMEA/H/C/006157	Celltrion Healthcare Hungary Kft.	2025/02/14	Authorised
Avtozma	Human	tocilizumab	tocilizumab	EMEA/H/C/006196	Celltrion Healthcare Hungary Kft.	2025/02/14	Authorised
Yesintek	Human	ustekinumab	ustekinumab	EMEA/H/C/006444	Biosimilar Collaborations Ireland Limited	2025/02/14	Authorised
Obodence	Human	denosumab	denosumab	EMEA/H/C/006424	Samsung Bioepis NL B.V.	2025/02/12	Authorised
Zefylti	Human	filgrastim	filgrastim	EMEA/H/C/006400	CuraTeQ Biologics s.r.o	2025/02/12	Authorised
Eydenzelt	Human	aflibercept	aflibercept	EMEA/H/C/005899	Celltrion Healthcare Hungary Kft.	2025/02/12	Authorised

商品名称Name of medicine	*示例：Zokinvy（英文）
药品通用名或非专利名称International non-proprietary name (INN) / common name	*示例：lonafarnib（英文）
活性成分Active substance	*示例：lonafarnib（英文）
产品号EMA product number	*示例：EMEA/H/C/005271
ATC编号ATC code	*示例：L01EA06
上市许可开发者/申请人/持有人Marketing authorisation developer / applicant / holder	*示例：Janssen
药物治疗学分组Pharmacotherapeutic group	*示例：Antineoplastic
适应症Therapeutic indication	*示例：leukaemia
许可状态Medicine status
上市许可日期Marketing authorisation date	-